1. Home
  2. AMPH vs JBGS Comparison

AMPH vs JBGS Comparison

Compare AMPH & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • JBGS
  • Stock Information
  • Founded
  • AMPH 1996
  • JBGS 2016
  • Country
  • AMPH United States
  • JBGS United States
  • Employees
  • AMPH N/A
  • JBGS N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • JBGS Real Estate Investment Trusts
  • Sector
  • AMPH Health Care
  • JBGS Real Estate
  • Exchange
  • AMPH Nasdaq
  • JBGS Nasdaq
  • Market Cap
  • AMPH 1.2B
  • JBGS 1.1B
  • IPO Year
  • AMPH 2014
  • JBGS 2017
  • Fundamental
  • Price
  • AMPH $26.05
  • JBGS $17.45
  • Analyst Decision
  • AMPH Buy
  • JBGS Sell
  • Analyst Count
  • AMPH 6
  • JBGS 2
  • Target Price
  • AMPH $35.17
  • JBGS $16.50
  • AVG Volume (30 Days)
  • AMPH 453.0K
  • JBGS 631.7K
  • Earning Date
  • AMPH 11-06-2025
  • JBGS 10-28-2025
  • Dividend Yield
  • AMPH N/A
  • JBGS 3.90%
  • EPS Growth
  • AMPH N/A
  • JBGS N/A
  • EPS
  • AMPH 2.27
  • JBGS N/A
  • Revenue
  • AMPH $723,305,000.00
  • JBGS $501,226,000.00
  • Revenue This Year
  • AMPH $0.74
  • JBGS N/A
  • Revenue Next Year
  • AMPH $5.63
  • JBGS $1.79
  • P/E Ratio
  • AMPH $11.48
  • JBGS N/A
  • Revenue Growth
  • AMPH N/A
  • JBGS N/A
  • 52 Week Low
  • AMPH $20.39
  • JBGS $13.28
  • 52 Week High
  • AMPH $46.43
  • JBGS $24.30
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 53.17
  • JBGS 26.21
  • Support Level
  • AMPH $23.67
  • JBGS $18.00
  • Resistance Level
  • AMPH $29.00
  • JBGS $18.37
  • Average True Range (ATR)
  • AMPH 1.38
  • JBGS 0.62
  • MACD
  • AMPH 0.24
  • JBGS -0.12
  • Stochastic Oscillator
  • AMPH 43.81
  • JBGS 3.02

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About JBGS JBG SMITH Properties

JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party asset management and real estate services. It generates maximum revenue from the commercial segment.

Share on Social Networks: